303 related articles for article (PubMed ID: 7750284)
1. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
Fuhrmann U; Slater EP; Fritzemeier KH
Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
[TBL] [Abstract][Full Text] [Related]
2. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
3. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Kloosterboer HJ; Vonk-Noordegraaf CA; Turpijn EW
Contraception; 1988 Sep; 38(3):325-32. PubMed ID: 3139361
[TBL] [Abstract][Full Text] [Related]
4. Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin.
Bergink EW; Hamburger AD; de Jager E; van der Vies J
J Steroid Biochem; 1981 Feb; 14(2):175-83. PubMed ID: 6451769
[TBL] [Abstract][Full Text] [Related]
5. Nestorone: a progestin with a unique pharmacological profile.
Kumar N; Koide SS; Tsong Y; Sundaram K
Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
[TBL] [Abstract][Full Text] [Related]
6. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
7. Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones.
Schoonen WG; Deckers G; de Gooijer ME; de Ries R; Mathijssen-Mommers G; Hamersma H; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2000 Oct; 74(3):109-23. PubMed ID: 11086230
[TBL] [Abstract][Full Text] [Related]
8. Desogestrel, norgestimate, and gestodene: the newer progestins.
Kaplan B
Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
[TBL] [Abstract][Full Text] [Related]
9. Gestodene: a novel synthetic progestin--characterization of binding to receptor and serum proteins.
Pollow K; Juchem M; Grill HJ; Elger W; Beier S; Henderson D; Schmidt-Gollwitzer K; Manz B
Contraception; 1989 Sep; 40(3):325-41. PubMed ID: 2548807
[TBL] [Abstract][Full Text] [Related]
10. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.
Phillips A; Demarest K; Hahn DW; Wong F; McGuire JL
Contraception; 1990 Apr; 41(4):399-410. PubMed ID: 2335104
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the new progestogens in combination oral contraceptives.
Rebar RW; Zeserson K
Contraception; 1991 Jul; 44(1):1-10. PubMed ID: 1832625
[TBL] [Abstract][Full Text] [Related]
12. Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
Juchem M; Pollow K
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2171-83. PubMed ID: 2175153
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
Phillips A; Hahn DW; McGuire JL
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives.
Collins DC
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1508-13. PubMed ID: 8178899
[TBL] [Abstract][Full Text] [Related]
15. The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites.
Lemus AE; Zaga V; Santillán R; García GA; Grillasca I; Damián-Matsumura P; Jackson KJ; Cooney AJ; Larrea F; Pérez-Palacios G
J Endocrinol; 2000 Jun; 165(3):693-702. PubMed ID: 10828854
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of trimegestone: a new potent and selective progestin.
Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
[TBL] [Abstract][Full Text] [Related]
17. Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
Kuhnz W; Pfeffer M; al-Yacoub G
J Steroid Biochem; 1990 Feb; 35(2):313-8. PubMed ID: 2308344
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacology of newer progestogens.
Kuhl H
Drugs; 1996 Feb; 51(2):188-215. PubMed ID: 8808163
[TBL] [Abstract][Full Text] [Related]
19. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
Hammerstein J; Daume E; Simon A; Winkler UH; Schindler AE; Back DJ; Ward S; Neiss A
Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
[TBL] [Abstract][Full Text] [Related]
20. Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals.
Deckers GH; Schoonen WG; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2000 Oct; 74(3):83-92. PubMed ID: 11086227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
